Literature DB >> 11512152

Membrane and cell wall targets in Aspergillus fumigatus.

A Beauvais1, J P Latgé.   

Abstract

Antifungal drugs directed against the human opportunistic fungal pathogen Aspergillus fumigatus are limited in number and ergosterol-targeted: the polyenes bind to the membrane ergosterol and the azoles block the ergosterol biosynthesis pathway. The efficacy of the drugs currently available for clinical use (amphotericin B and itraconazole) is limited and the frequent occurrence of therapeutic failures in the treatment of invasive aspergillosis emphasizes the need for the development of new agents. Cell wall biosynthetic pathways have been recognized for a long time as essential and unique specific drug targets. Recent studies of the chemical organization of the cell wall of A. fumigatus together with comparative analysis of yeast cell wall data have shown that beta 1-3 glucan branching and chitin-beta 1-3 glucan binding are essential exocellular enzymatic steps in cell wall biosynthesis. The enzymes involved in the biosynthesis and remodeling of cell wall polysaccharides especially in A. fumigatus are reviewed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11512152     DOI: 10.1054/drup.2001.0185

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  19 in total

1.  Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates.

Authors:  Sevtap Arikan; Victor Paetznick; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

2.  Regulation of Neurospora crassa cell wall remodeling via the cot-1 pathway is mediated by gul-1.

Authors:  Inbal Herold; Oded Yarden
Journal:  Curr Genet       Date:  2016-06-30       Impact factor: 3.886

3.  Allergens/Antigens, toxins and polyketides of important Aspergillus species.

Authors:  Preetida J Bhetariya; Taruna Madan; Seemi Farhat Basir; Anupam Varma; Sarma P Usha
Journal:  Indian J Clin Biochem       Date:  2011-05-19

4.  Two alpha(1-3) glucan synthases with different functions in Aspergillus fumigatus.

Authors:  A Beauvais; D Maubon; S Park; W Morelle; M Tanguy; M Huerre; D S Perlin; J P Latgé
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

5.  Differences among the cell wall galactomannans from Aspergillus wentii and Chaetosartorya chrysella and that of Aspergillus fumigatus.

Authors:  Begoña Gómez-Miranda; Alicia Prieto; Juan Antonio Leal; Oussama Ahrazem; Jesús Jiménez-Barbero; Manuel Bernabé
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

6.  Two novel, putatively cell wall-associated and glycosylphosphatidylinositol-anchored alpha-glucanotransferase enzymes of Aspergillus niger.

Authors:  R M van der Kaaij; X-L Yuan; A Franken; A F J Ram; P J Punt; M J E C van der Maarel; L Dijkhuizen
Journal:  Eukaryot Cell       Date:  2007-05-11

7.  Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition.

Authors:  Ying Jie Ma; Andrea Doni; Tina Hummelshøj; Christian Honoré; Antonio Bastone; Alberto Mantovani; Nicole M Thielens; Peter Garred
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

8.  Molecular characterization of an adaptive response to alkylating agents in the opportunistic pathogen Aspergillus fumigatus.

Authors:  Karen A O'Hanlon; Geoffrey P Margison; Amy Hatch; David A Fitzpatrick; Rebecca A Owens; Sean Doyle; Gary W Jones
Journal:  Nucleic Acids Res       Date:  2012-06-04       Impact factor: 16.971

Review 9.  Structure and biosynthesis of fungal cell walls: methodological approaches.

Authors:  V Farkas
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.629

10.  Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.

Authors:  Sang Taek Heo; Alexander M Tatara; Cristina Jiménez-Ortigosa; Ying Jiang; Russell E Lewis; Jeffrey Tarrand; Frank Tverdek; Nathaniel D Albert; Paul E Verweij; Jacques F Meis; Antonios G Mikos; David S Perlin; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.